{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:44:15Z","timestamp":1793943855181,"version":"4.8.0"},"reference-count":207,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073778"],"award-info":[{"award-number":["82073778"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104106"],"award-info":[{"award-number":["82104106"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160666"],"award-info":[{"award-number":["82160666"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.apsb.2026.04.007","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T23:29:06Z","timestamp":1776468546000},"page":"3582-3602","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The mechanisms and strategies for Alzheimer\u2019s disease prevention: An update"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0041-0475","authenticated-orcid":false,"given":"Mingfeng","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuoya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxiu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenfei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yedan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jishan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1408-5135","authenticated-orcid":false,"given":"Zhonggao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2026.04.007_bib1","first-page":"1","article-title":"NIH state-of-the-science conference statement: preventing Alzheimer\u2019s disease and cognitive decline","volume":"27","author":"Daviglus","year":"2010","journal-title":"NIH Consens State Sci Statements"},{"key":"10.1016\/j.apsb.2026.04.007_bib2","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer\u2019s disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2026.04.007_bib3","first-page":"201","article-title":"Amyloid precursor protein: a regulatory hub in Alzheimer\u2019s disease","volume":"15","author":"Chen","year":"2024","journal-title":"Aging Dis"},{"key":"10.1016\/j.apsb.2026.04.007_bib4","first-page":"394","article-title":"Amyloid, Tau, and APOE in Alzheimer\u2019s disease: impact on white matter tracts","volume":"30","author":"Chandio","year":"2025","journal-title":"Pac Symp Biocomput"},{"key":"10.1016\/j.apsb.2026.04.007_bib5","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1002\/alz.13809","article-title":"2024 Alzheimer\u2019s disease facts and figures","volume":"20","year":"2024","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.apsb.2026.04.007_bib6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.14283\/jpad.2021.15","article-title":"The epidemiology of Alzheimer\u2019s disease modifiable risk factors and prevention","volume":"8","author":"Zhang","year":"2021","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.apsb.2026.04.007_bib7","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1002\/alz.13027","article-title":"The structural and social determinants of Alzheimer\u2019s disease related dementias","volume":"19","author":"Adkins-Jackson","year":"2023","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.apsb.2026.04.007_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241813900","article-title":"Treatment of Alzheimer\u2019s disease: beyond symptomatic therapies","volume":"24","author":"Buccellato","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.04.007_bib9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.62347\/MTWV3745","article-title":"Caveolae with serotonin and NMDA receptors as promising targets for the treatment of Alzheimer\u2019s disease","volume":"16","author":"Nakashima","year":"2024","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"key":"10.1016\/j.apsb.2026.04.007_bib10","doi-asserted-by":"crossref","first-page":"6518","DOI":"10.3390\/ijms24076518","article-title":"Inflammatory processes in Alzheimer\u2019s disease-pathomechanism, diagnosis and treatment: a review","volume":"24","author":"Twarowski","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.04.007_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232213954","article-title":"Alzheimer\u2019s disease: treatment strategies and their limitations","volume":"23","author":"Passeri","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.04.007_bib12","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.7150\/ijbs.57078","article-title":"Interaction between A\u03b2 and Tau in the pathogenesis of Alzheimer\u2019s disease","volume":"17","author":"Zhang","year":"2021","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.apsb.2026.04.007_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.semcdb.2022.05.028","article-title":"Synapse pathology in Alzheimer\u2019s disease","volume":"139","author":"Griffiths","year":"2023","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.apsb.2026.04.007_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914499","article-title":"Anti-amyloid therapies for Alzheimer\u2019s disease and the amyloid cascade hypothesis","volume":"24","author":"Fedele","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.04.007_bib15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40659-022-00404-3","article-title":"Inflammation context in Alzheimer\u2019s disease, a relationship intricate to define","volume":"55","author":"Novoa","year":"2022","journal-title":"Biol Res"},{"key":"10.1016\/j.apsb.2026.04.007_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102600","article-title":"Rlip76 in ageing and Alzheimer\u2019s disease: focus on oxidative stress and mitochondrial mechanisms","volume":"103","author":"Bandaru","year":"2025","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.apsb.2026.04.007_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102955","article-title":"Oxygen metabolism abnormality and Alzheimer\u2019s disease: an update","volume":"68","author":"Liu","year":"2023","journal-title":"Redox Biol"},{"key":"10.1016\/j.apsb.2026.04.007_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115522","article-title":"Alzheimer\u2019s disease: insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs","volume":"211","author":"Monteiro","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.apsb.2026.04.007_bib19","doi-asserted-by":"crossref","first-page":"9207","DOI":"10.3390\/ijms22179207","article-title":"Tau protein interaction partners and their roles in Alzheimer\u2019s disease and other tauopathies","volume":"22","author":"Sinsky","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.04.007_bib20","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S1474-4422(22)00168-5","article-title":"Tau biomarkers in Alzheimer\u2019s disease: towards implementation in clinical practice and trials","volume":"21","author":"Ossenkoppele","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.apsb.2026.04.007_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14403","article-title":"The tau isoform 1N4R confers vulnerability of MAPT knockout human iPSC-derived neurons to amyloid beta and phosphorylated tau-induced neuronal dysfunction","volume":"21","author":"Buchholz","year":"2025","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.apsb.2026.04.007_bib22","doi-asserted-by":"crossref","first-page":"S335","DOI":"10.3233\/JAD-221064","article-title":"Microglia-mediated neurovascular unit dysfunction in Alzheimer\u2019s disease","volume":"94","author":"Huang","year":"2023","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.apsb.2026.04.007_bib23","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/s41586-025-08589-9","article-title":"Glycocalyx dysregulation impairs blood\u2013brain barrier in ageing and disease","volume":"639","author":"Shi","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.04.007_bib24","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1016\/j.cell.2023.08.021","article-title":"Alzheimer\u2019s disease: from immunotherapy to immunoprevention","volume":"186","author":"Jucker","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2026.04.007_bib25","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00401-020-02215-w","article-title":"Cerebral blood flow decrease as an early pathological mechanism in Alzheimer\u2019s disease","volume":"140","author":"Korte","year":"2020","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.apsb.2026.04.007_bib26","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1038\/s41593-024-01763-8","article-title":"Synergistic association of A\u03b2 and tau pathology with cortical neurophysiology and cognitive decline in asymptomatic older adults","volume":"27","author":"Gallego-Rudolf","year":"2024","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.apsb.2026.04.007_bib27","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1038\/s41593-024-01737-w","article-title":"Proteomic changes in Alzheimer\u2019s disease associated with progressive A\u03b2 plaque and tau tangle pathologies","volume":"27","author":"Pichet","year":"2024","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.apsb.2026.04.007_bib28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neuroscience.2024.08.008","article-title":"Alzheimer\u2019s disease and sleep disorders: a bidirectional relationship","volume":"557","author":"Chen","year":"2024","journal-title":"Neuroscience"},{"key":"10.1016\/j.apsb.2026.04.007_bib29","doi-asserted-by":"crossref","first-page":"197","DOI":"10.31083\/j.jin2311197","article-title":"Molecular insights into tau pathology and its therapeutic strategies in Alzheimer\u2019s disease","volume":"23","author":"Zhou","year":"2024","journal-title":"J Integr Neurosci"},{"key":"10.1016\/j.apsb.2026.04.007_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118085","article-title":"Novel dual-targeting PROTAC degraders of GSK-3\u03b2 and CDK5: a promising approach for pancreatic cancer treatment","volume":"120","author":"Neerasa","year":"2025","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.apsb.2026.04.007_bib31","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s12276-022-00754-8","article-title":"\u03b3-Secretase in Alzheimer\u2019s disease","volume":"54","author":"Hur","year":"2022","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.apsb.2026.04.007_bib32","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.3390\/ijms21041413","article-title":"APP osaka mutation in familial Alzheimer\u2019s disease-its discovery, phenotypes, and mechanism of recessive inheritance","volume":"21","author":"Tomiyama","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.04.007_bib33","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13195-024-01504-w","article-title":"APP dyshomeostasis in the pathogenesis of Alzheimer\u2019s disease: implications for current drug targets","volume":"16","author":"Sirisi","year":"2024","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.apsb.2026.04.007_bib34","doi-asserted-by":"crossref","first-page":"8417","DOI":"10.3390\/ijms24098417","article-title":"Presenilin-1 (PSEN1) mutations: clinical phenotypes beyond Alzheimer\u2019s disease","volume":"24","author":"Yang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.04.007_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113310","article-title":"Cerebral organoids derived from patients with Alzheimer\u2019s disease with PSEN1\/2 mutations have defective tissue patterning and altered development","volume":"42","author":"Vanova","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2026.04.007_bib36","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1007\/s12011-023-03932-5","article-title":"Might diet, APOE\u2013APOA1 axis, and iron metabolism provide clues about the discrepancy in Alzheimer\u2019s disease occurrence between humans and chimpanzees? A bioinformatics-based re-analysis of gene expression data on mice fed with human and chimpanzee diets","volume":"202","author":"Kumar","year":"2024","journal-title":"Biol Trace Elem Res"},{"key":"10.1016\/j.apsb.2026.04.007_bib37","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000538486","article-title":"Feature importance analysis and machine learning for Alzheimer\u2019s disease early detection: feature fusion of the hippocampus, entorhinal cortex, and standardized uptake value ratio","volume":"8","author":"Hassouneh","year":"2024","journal-title":"Digit Biomark"},{"key":"10.1016\/j.apsb.2026.04.007_bib38","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/joim.13244","article-title":"Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer\u2019s disease (MCI and dementia) in primary care: a review and synthesis","volume":"290","author":"Liss","year":"2021","journal-title":"J Intern Med"},{"key":"10.1016\/j.apsb.2026.04.007_bib39","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/alz.12724","article-title":"Plasma A\u03b242\/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer\u2019s disease continuum: a cross-sectional and longitudinal study in the AIBL cohort","volume":"19","author":"Chatterjee","year":"2023","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.apsb.2026.04.007_bib40","doi-asserted-by":"crossref","first-page":"7537","DOI":"10.1007\/s00415-024-12669-7","article-title":"Plasma NfL, GFAP, amyloid, and p-tau species as prognostic biomarkers in Parkinson\u2019s disease","volume":"271","author":"Pilotto","year":"2024","journal-title":"J Neurol"},{"key":"10.1016\/j.apsb.2026.04.007_bib41","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.3390\/ijms22052761","article-title":"Machine learning and novel biomarkers for the diagnosis of Alzheimer\u2019s disease","volume":"22","author":"Chang","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.04.007_bib42","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1186\/s12967-024-05767-7","article-title":"CSF and blood levels of Neurofilaments, T-Tau, P-Tau, and Abeta-42 in amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"22","author":"Agah","year":"2024","journal-title":"J Transl Med"},{"key":"10.1016\/j.apsb.2026.04.007_bib43","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.apsb.2026.04.007_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14536","article-title":"Plasma p-tau217 and p-tau217\/A\u03b21-42 are effective biomarkers for identifying CSF- and PET imaging-diagnosed Alzheimer\u2019s disease: insights for research and clinical practice","volume":"21","author":"Zhong","year":"2025","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.apsb.2026.04.007_bib45","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/brain\/awaf002","article-title":"Perceptual rivalry in neuroscience, magic and philosophy","volume":"148","author":"Hohlfeld","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.apsb.2026.04.007_bib46","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1056\/NEJMoa2310168","article-title":"Biomarker changes during 20 years preceding Alzheimer\u2019s disease","volume":"390","author":"Jia","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.04.007_bib47","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13195-023-01296-5","article-title":"Performance of plasma A\u03b242\/40, measured using a fully automated immunoassay, across a broad patient population in identifying amyloid status","volume":"15","author":"Bun","year":"2023","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.apsb.2026.04.007_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2024.116396","article-title":"An optimized UPLC\u2013MS\/MS method for human plasma amyloid-\u03b2 42 and 40 measurement and application in Alzheimer\u2019s disease diagnosis","volume":"250","author":"Zhang","year":"2024","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.apsb.2026.04.007_bib49","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12916-024-03418-8","article-title":"Peripheral GFAP and NfL as early biomarkers for dementia: longitudinal insights from the UK Biobank","volume":"22","author":"Wang","year":"2024","journal-title":"BMC Med"},{"key":"10.1016\/j.apsb.2026.04.007_bib50","doi-asserted-by":"crossref","first-page":"fcae396","DOI":"10.1093\/braincomms\/fcae396","article-title":"Glial fibrillary acidic protein in Alzheimer\u2019s disease: a narrative review","volume":"6","author":"Leipp","year":"2024","journal-title":"Brain Commun"},{"key":"10.1016\/j.apsb.2026.04.007_bib51","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.1002\/alz.13318","article-title":"Longitudinal blood biomarker trajectories in preclinical Alzheimer\u2019s disease","volume":"19","author":"Yakoub","year":"2023","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.apsb.2026.04.007_bib52","doi-asserted-by":"crossref","first-page":"6984","DOI":"10.1002\/alz.14188","article-title":"Distinct regional vulnerability to A\u03b2 and iron accumulation in post mortem AD brains","volume":"20","author":"Yao","year":"2024","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.apsb.2026.04.007_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14338","article-title":"Updated appropriate use criteria for amyloid and tau PET: a report from the Alzheimer\u2019s Association and Society for Nuclear Medicine and Molecular Imaging Workgroup","volume":"21","author":"Rabinovici","year":"2025","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.apsb.2026.04.007_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.706695","article-title":"Validity and cultural generalisability of a 5-minute AI-based, computerised cognitive assessment in mild cognitive impairment and Alzheimer\u2019s dementia","volume":"12","author":"Kalafatis","year":"2021","journal-title":"Front Psychiatr"},{"key":"10.1016\/j.apsb.2026.04.007_bib55","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1038\/s41598-023-30075-3","article-title":"EEG resting-state networks in Alzheimer\u2019s disease associated with clinical symptoms","volume":"13","author":"Aoki","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2026.04.007_bib56","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s40291-024-00738-6","article-title":"Molecular therapeutics in development to treat Alzheimer\u2019s disease","volume":"29","author":"Tartaglia","year":"2025","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.apsb.2026.04.007_bib57","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41582-023-00869-0","article-title":"Treatments for AD: towards the right target at the right time","volume":"19","author":"van der Flier","year":"2023","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.apsb.2026.04.007_bib58","doi-asserted-by":"crossref","first-page":"362","DOI":"10.14283\/jpad.2023.30","article-title":"Lecanemab: appropriate use recommendations","volume":"10","author":"Cummings","year":"2023","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.apsb.2026.04.007_bib59","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s40265-023-01851-2","article-title":"Lecanemab: first approval","volume":"83","author":"Hoy","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.apsb.2026.04.007_bib60","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.04.007_bib61","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13195-024-01441-8","article-title":"Updated safety results from phase 3 lecanemab study in early Alzheimer\u2019s disease","volume":"16","author":"Honig","year":"2024","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.apsb.2026.04.007_bib62","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41582-022-00768-w","article-title":"Lecanemab trial in AD brings hope but requires greater clarity","volume":"19","author":"Thambisetty","year":"2023","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.apsb.2026.04.007_bib63","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1212\/WNL.0000000000207505","article-title":"Lecanemab: looking before we leap","volume":"101","author":"Burke","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.apsb.2026.04.007_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40261-023-01331-1","article-title":"Lecanemab: more questions than answers","volume":"44","author":"Kaur","year":"2024","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.apsb.2026.04.007_bib65","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1056\/NEJMoa2304430","article-title":"Two phase 3 trials of gantenerumab in early Alzheimer\u2019s disease","volume":"389","author":"Bateman","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.04.007_bib66","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13195-022-01110-8","article-title":"Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer\u2019s disease","volume":"14","author":"Bateman","year":"2022","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.apsb.2026.04.007_bib67","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.apsb.2026.04.007_bib68","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2023.11703","article-title":"Amyloid-targeting monoclonal antibodies for Alzheimer disease","volume":"330","author":"Rabinovici","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.apsb.2026.04.007_bib69","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/B978-0-323-98817-9.00029-6","article-title":"Passive tau-based immunotherapy for tauopathies","volume":"196","author":"Panza","year":"2023","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.apsb.2026.04.007_bib70","doi-asserted-by":"crossref","first-page":"e1391","DOI":"10.1212\/WNL.0000000000207663","article-title":"Randomized phase II study of the safety and efficacy of semorinemab in participants with mild-to-moderate Alzheimer disease: Lauriet","volume":"101","author":"Monteiro","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.apsb.2026.04.007_bib71","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/13543784.2023.2233892","article-title":"Clinical development of passive tau-based immunotherapeutics for treating primary and secondary tauopathies","volume":"32","author":"Panza","year":"2023","journal-title":"Expet Opin Invest Drugs"},{"key":"10.1016\/j.apsb.2026.04.007_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102404","article-title":"Discovery and characterization of stereodefined PMO-gapmers targeting tau","volume":"36","author":"Kanatsu","year":"2025","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.apsb.2026.04.007_bib73","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1016\/j.apsb.2023.04.008","article-title":"GSDMD in peripheral myeloid cells regulates microglial immune training and neuroinflammation in Parkinson\u2019s disease","volume":"13","author":"Wang","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.04.007_bib74","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s13195-024-01599-1","article-title":"Preclinical and first-in-human evaluation of AL002, a novel TREM2 agonistic antibody for Alzheimer\u2019s disease","volume":"16","author":"Long","year":"2024","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.apsb.2026.04.007_bib75","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13195-023-01169-x","article-title":"Masitinib for mild-to-moderate Alzheimer\u2019s disease: results from a randomized, placebo-controlled, phase 3, clinical trial","volume":"15","author":"Dubois","year":"2023","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.apsb.2026.04.007_bib76","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1038\/s41591-025-03574-1","article-title":"Microglial mechanisms drive amyloid-\u03b2 clearance in immunized patients with Alzheimer\u2019s disease","volume":"31","author":"van Olst","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2026.04.007_bib77","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jare.2021.07.001","article-title":"CRISPR\/Cas9 gene editing: new hope for Alzheimer\u2019s disease therapeutics","volume":"40","author":"Bhardwaj","year":"2022","journal-title":"J Adv Res"},{"key":"10.1016\/j.apsb.2026.04.007_bib78","article-title":"Long term rescue of Alzheimer\u2019s deficits in vivo by one-time gene-editing of App C-terminus","author":"Aulston","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.apsb.2026.04.007_bib79","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s40120-020-00218-z","article-title":"CRISPR-Cas9: a promising genome editing therapeutic tool for Alzheimer\u2019s disease\u2014a narrative review","volume":"9","author":"Barman","year":"2020","journal-title":"Neurol Ther"},{"key":"10.1016\/j.apsb.2026.04.007_bib80","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3390\/ijms24010778","article-title":"Apoe4 and Alzheimer\u2019s disease pathogenesis-mitochondrial deregulation and targeted therapeutic strategies","volume":"24","author":"Pires","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.04.007_bib81","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1001\/jamaneurol.2024.0991","article-title":"Downstream biomarker effects of gantenerumab or solanezumab in dominantly inherited alzheimer disease: the DIAN-TU-001 randomized clinical trial","volume":"81","author":"Wagemann","year":"2024","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.apsb.2026.04.007_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2022.107134","article-title":"Efficacy and safety of donepezil for mild cognitive impairment: a systematic review and meta-analysis","volume":"213","author":"Zhang","year":"2022","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.apsb.2026.04.007_bib83","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/14737175.2024.2355981","article-title":"The donepezil transdermal system for the treatment of patients with mild, moderate, or severe Alzheimer\u2019s disease: a critical review","volume":"24","author":"Buck","year":"2024","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.apsb.2026.04.007_bib84","doi-asserted-by":"crossref","first-page":"29","DOI":"10.12809\/eaap2353","article-title":"Rivastigmine for treatment-refractory posttraumatic stress disorder: a systematic review","volume":"34","author":"Maguire","year":"2024","journal-title":"East Asian Arch Psychiatry"},{"key":"10.1016\/j.apsb.2026.04.007_bib85","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0310900","article-title":"Effects of rivastigmine on gait in patients with neurodegenerative disorders: a systematic review and meta-analysis","volume":"19","author":"Shim","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2026.04.007_bib86","first-page":"Cd001747","article-title":"Galantamine for dementia due to Alzheimer\u2019s disease and mild cognitive impairment","volume":"11","author":"Lim","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.apsb.2026.04.007_bib87","series-title":"StatPearls [Internet]","article-title":"Galantamine","author":"Kalola","year":"2026"},{"key":"10.1016\/j.apsb.2026.04.007_bib88","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.jacep.2024.03.028","article-title":"Memantine and incident atrial fibrillation or flutter in Alzheimer\u2019s disease: a propensity score-matched analysis","volume":"10","author":"Rawlley","year":"2024","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.apsb.2026.04.007_bib89","series-title":"StatPearls [Internet]","article-title":"Memantine","author":"Kuns","year":"2026"},{"key":"10.1016\/j.apsb.2026.04.007_bib90","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2174\/1872208316666220302115901","article-title":"Challenges and approaches of drugs such as memantine, donepezil, rivastigmine, and aducanumab in the treatment, control and management of Alzheimer\u2019s disease","volume":"16","author":"Saeedi","year":"2022","journal-title":"Recent Pat Biotechnol"},{"key":"10.1016\/j.apsb.2026.04.007_bib91","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","article-title":"Donanemab in early Alzheimer\u2019s disease","volume":"384","author":"Mintun","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.04.007_bib92","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/cpt.2875","article-title":"Donanemab population pharmacokinetics, amyloid plaque reduction, and safety in participants with Alzheimer\u2019s disease","volume":"113","author":"Gueorguieva","year":"2023","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.apsb.2026.04.007_bib93","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13195-021-00795-7","article-title":"A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer\u2019s dementia","volume":"13","author":"Xiao","year":"2021","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.apsb.2026.04.007_bib94","first-page":"741","article-title":"Efficacy and safety of sodium oligomannate in the treatment of Alzheimer\u2019s disease","volume":"35","author":"Zhang","year":"2022","journal-title":"Pak J Pharm Sci"},{"key":"10.1016\/j.apsb.2026.04.007_bib95","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40478-020-0884-2","article-title":"Pre-clinical characterisation of E2814, a high-affinity antibody targeting the microtubule-binding repeat domain of tau for passive immunotherapy in Alzheimer\u2019s disease","volume":"8","author":"Roberts","year":"2020","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.apsb.2026.04.007_bib96","article-title":"Beyond lecanemab: examining Phase III potential in Alzheimer\u2019s therapeutics","volume":"3","author":"Osaka","year":"2024","journal-title":"PCN Rep"},{"key":"10.1016\/j.apsb.2026.04.007_bib97","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1080\/14656566.2024.2360069","article-title":"Review of valiltramiprosate (ALZ-801) for the treatment of Alzheimer\u2019s disease: a novel small molecule with disease modifying potential","volume":"25","author":"Lee","year":"2024","journal-title":"Expet Opin Pharmacother"},{"key":"10.1016\/j.apsb.2026.04.007_bib98","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13195-020-00663-w","article-title":"Aducanumab, gantenerumab, BAN2401, and ALZ-801-the first wave of amyloid-targeting drugs for Alzheimer\u2019s disease with potential for near term approval","volume":"12","author":"Tolar","year":"2020","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.apsb.2026.04.007_bib99","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202402622R","article-title":"ALZ-801 prevents amyloid \u03b2-protein assembly and reduces cytotoxicity: a preclinical experimental study","volume":"39","author":"Muramatsu","year":"2025","journal-title":"FASEB J"},{"key":"10.1016\/j.apsb.2026.04.007_bib100","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.2174\/1871527321666220610104908","article-title":"Selective inhibition of soluble TNF using XPro1595 improves hippocampal pathology to promote improved neurological recovery following traumatic brain injury in mice","volume":"22","author":"Larson","year":"2023","journal-title":"CNS Neurol Disord: Drug Targets"},{"key":"10.1016\/j.apsb.2026.04.007_bib101","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3233\/JPD-140410","article-title":"Peripheral administration of the selective inhibitor of soluble tumor necrosis factor (TNF) XPro\u00ae1595 attenuates nigral cell loss and glial activation in 6-OHDA hemiparkinsonian rats","volume":"4","author":"Barnum","year":"2014","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.apsb.2026.04.007_bib102","first-page":"1299","article-title":"Meta-analysis of modifiable risk factors for Alzheimer\u2019s disease","volume":"86","author":"Xu","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.apsb.2026.04.007_bib103","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1136\/jnnp-2019-321913","article-title":"Evidence-based prevention of Alzheimer\u2019s disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials","volume":"91","author":"Yu","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.apsb.2026.04.007_bib104","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jamaneurol.2023.3861","article-title":"Exploratory Tau biomarker results from a multiple ascending-dose study of BIIB080 in Alzheimer disease: a randomized clinical trial","volume":"80","author":"Edwards","year":"2023","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.apsb.2026.04.007_bib105","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/alz.12302","article-title":"Preclinical and clinical biomarker studies of CT1812: a novel approach to Alzheimer\u2019s disease modification","volume":"17","author":"Izzo","year":"2021","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.apsb.2026.04.007_bib106","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.biopsych.2023.10.008","article-title":"Depression in Alzheimer\u2019s disease: epidemiology, mechanisms, and treatment","volume":"95","author":"Huang","year":"2024","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.apsb.2026.04.007_bib107","doi-asserted-by":"crossref","first-page":"9690","DOI":"10.3390\/ijms25179690","article-title":"Alzheimer\u2019s disease pathology and assistive nanotheranostic approaches for its therapeutic interventions","volume":"25","author":"Dey","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.04.007_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102309","article-title":"Mechanistic insights and emerging therapeutic stratagems for Alzheimer\u2019s disease","volume":"97","author":"Rajendran","year":"2024","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.apsb.2026.04.007_bib109","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nrcardio.2010.161","article-title":"The relationship between blood pressure and cognitive function","volume":"7","author":"Novak","year":"2010","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.apsb.2026.04.007_bib110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0295658","article-title":"Association between use of antihypertensives and cognitive decline in the elderly\u2014A retrospective observational study","volume":"18","author":"Dhami","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2026.04.007_bib111","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1007\/s10072-023-07208-7","article-title":"Advancements in investigating the role of cerebral small vein loss in Alzheimer\u2019s disease-related pathological changes","volume":"45","author":"Hu","year":"2024","journal-title":"Neurol Sci"},{"key":"10.1016\/j.apsb.2026.04.007_bib112","doi-asserted-by":"crossref","first-page":"S345","DOI":"10.3233\/JAD-240495","article-title":"Metformin as a potential prevention strategy for Alzheimer\u2019s disease and Alzheimer\u2019s disease related dementias","volume":"101","author":"Tahmi","year":"2024","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.apsb.2026.04.007_bib113","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1007\/s00125-022-05743-0","article-title":"Evaluating the efficacy and mechanism of metformin targets on reducing Alzheimer\u2019s disease risk in the general population: a Mendelian randomisation study","volume":"65","author":"Zheng","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/j.apsb.2026.04.007_bib114","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.878304","article-title":"Association between specific type 2 diabetes therapies and risk of Alzheimer\u2019s disease and related dementias in propensity-score matched type 2 diabetic patients","volume":"14","author":"Torrandell-Haro","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.apsb.2026.04.007_bib115","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.3390\/biom12081015","article-title":"The role of metals in the neuroregenerative action of BDNF, GDNF, NGF and other neurotrophic factors","volume":"12","author":"Nicoletti","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.apsb.2026.04.007_bib116","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/bs.afnr.2021.01.003","article-title":"Zinc","volume":"96","author":"Skalny","year":"2021","journal-title":"Adv Food Nutr Res"},{"key":"10.1016\/j.apsb.2026.04.007_bib117","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1126\/science.8073293","article-title":"Rapid induction of Alzheimer A beta amyloid formation by zinc","volume":"265","author":"Bush","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.apsb.2026.04.007_bib118","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.3390\/biom10081164","article-title":"Zinc therapy in early Alzheimer\u2019s disease: safety and potential therapeutic efficacy","volume":"10","author":"Squitti","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.apsb.2026.04.007_bib119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12011-019-01892-3","article-title":"Role of zinc supplementation on ischemia\/reperfusion injury in various organs","volume":"196","author":"Akbari","year":"2020","journal-title":"Biol Trace Elem Res"},{"key":"10.1016\/j.apsb.2026.04.007_bib120","doi-asserted-by":"crossref","first-page":"7152","DOI":"10.3390\/ijms24087152","article-title":"Zinc in cardiovascular functions and diseases: epidemiology and molecular mechanisms for therapeutic development","volume":"24","author":"Hara","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.04.007_bib121","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1038\/cddis.2010.73","article-title":"Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction","volume":"1","author":"Corona","year":"2010","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.apsb.2026.04.007_bib122","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s10238-024-01302-6","article-title":"Role of zinc in health and disease","volume":"24","author":"Stiles","year":"2024","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.apsb.2026.04.007_bib123","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3390\/biom13050799","article-title":"Selenium and selenoproteins in health","volume":"13","author":"Zhang","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.apsb.2026.04.007_bib124","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.freeradbiomed.2022.07.022","article-title":"Selenoproteins in brain development and function","volume":"190","author":"Schweizer","year":"2022","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.apsb.2026.04.007_bib125","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s12011-018-1492-x","article-title":"Brain selenium in Alzheimer\u2019s disease (BRAIN SEAD study): a systematic review and meta-analysis","volume":"189","author":"Varikasuvu","year":"2019","journal-title":"Biol Trace Elem Res"},{"key":"10.1016\/j.apsb.2026.04.007_bib126","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.778613","article-title":"Large amino acid mimicking selenium-doped carbon quantum dots for multi-target therapy of Alzheimer\u2019s disease","volume":"12","author":"Zhou","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2026.04.007_bib127","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/biof.1003","article-title":"Selenium and cognitive impairment: a brief-review based on results from the EVA study","volume":"38","author":"Berr","year":"2012","journal-title":"Biofactors"},{"key":"10.1016\/j.apsb.2026.04.007_bib128","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2024.1369373","article-title":"The effect of selenium supplementation on oxidative stress, clinical and physiological symptoms in patients with migraine: a double-blinded randomized clinical trial","volume":"11","author":"Balali","year":"2024","journal-title":"Front Nutr"},{"key":"10.1016\/j.apsb.2026.04.007_bib129","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.3390\/ijms23063327","article-title":"Regulatory miRNAs in cardiovascular and Alzheimer\u2019s disease: a focus on copper","volume":"23","author":"Sacco","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.04.007_bib130","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3233\/JAD-2010-101473","article-title":"Copper in Alzheimer\u2019s disease: a meta-analysis of serum,plasma, and cerebrospinal fluid studies","volume":"24","author":"Bucossi","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.apsb.2026.04.007_bib131","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jtemb.2012.04.012","article-title":"Copper dysfunction in Alzheimer\u2019s disease: from meta-analysis of biochemical studies to new insight into genetics","volume":"26","author":"Squitti","year":"2012","journal-title":"J Trace Elem Med Biol"},{"key":"10.1016\/j.apsb.2026.04.007_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102990","article-title":"Lead aggravates Alzheimer\u2019s disease pathology via mitochondrial copper accumulation regulated by COX17","volume":"69","author":"Huang","year":"2024","journal-title":"Redox Biol"},{"key":"10.1016\/j.apsb.2026.04.007_bib133","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/toxsci\/kfw081","article-title":"Copper exposure perturbs brain inflammatory responses and impairs clearance of amyloid-beta","volume":"152","author":"Kitazawa","year":"2016","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.apsb.2026.04.007_bib134","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(14)70117-6","article-title":"The role of iron in brain ageing and neurodegenerative disorders","volume":"13","author":"Ward","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.apsb.2026.04.007_bib135","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1148\/radiol.2020204157","article-title":"Iron accumulation, not \u03b2-Amyloid or brain volumes, is linked to cognition in older patients who are nondemented","volume":"298","author":"Chiang","year":"2021","journal-title":"Radiology"},{"key":"10.1016\/j.apsb.2026.04.007_bib136","doi-asserted-by":"crossref","first-page":"6760","DOI":"10.1038\/ncomms7760","article-title":"Ferritin levels in the cerebrospinal fluid predict Alzheimer\u2019s disease outcomes and are regulated by APOE","volume":"6","author":"Ayton","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.04.007_bib137","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.semcancer.2021.04.001","article-title":"Role of iron in cancer","volume":"76","author":"Salnikow","year":"2021","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.apsb.2026.04.007_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110173","article-title":"Essential metals in health and disease","volume":"367","author":"Jomova","year":"2022","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.apsb.2026.04.007_bib139","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3390\/nu10060730","article-title":"The role of magnesium in neurological disorders","volume":"10","author":"Kirkland","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.apsb.2026.04.007_bib140","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.neuroscience.2024.11.069","article-title":"Long-term potentiation in the hippocampus: from magnesium to memory","volume":"578","author":"Collingridge","year":"2025","journal-title":"Neuroscience"},{"key":"10.1016\/j.apsb.2026.04.007_bib141","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13041-014-0065-y","article-title":"Elevation of brain magnesium prevents synaptic loss and reverses cognitive deficits in Alzheimer\u2019s disease mouse model","volume":"7","author":"Li","year":"2014","journal-title":"Mol Brain"},{"key":"10.1016\/j.apsb.2026.04.007_bib142","article-title":"Magnesium protects cognitive functions and synaptic plasticity in streptozotocin-induced sporadic Alzheimer\u2019s model","volume":"9","author":"Xu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2026.04.007_bib143","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158670","article-title":"Effects of combining biofactors on bioenergetic parameters, A\u03b2 levels and survival in Alzheimer model organisms","volume":"23","author":"Babylon","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.04.007_bib144","article-title":"Association of circulating magnesium levels in patients with Alzheimer\u2019s disease from 1991 to 2021: a systematic review and meta-analysis","volume":"13","author":"Du","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.apsb.2026.04.007_bib145","article-title":"Mechanism of metal complexes in Alzheimer\u2019s disease","volume":"25","author":"Liu","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.04.007_bib146","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/jech-2023-221184","article-title":"Causal associations of antioxidants with Alzheimer\u2019s disease and cognitive function: a Mendelian randomisation study","volume":"78","author":"Wang","year":"2024","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.apsb.2026.04.007_bib147","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.neuron.2009.12.026","article-title":"Enhancement of learning and memory by elevating brain magnesium","volume":"65","author":"Slutsky","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.apsb.2026.04.007_bib148","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jalz.2013.05.1771","article-title":"Plasma nutrient status of patients with Alzheimer\u2019s disease: systematic review and meta-analysis","volume":"10","author":"Lopes da Silva","year":"2014","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.apsb.2026.04.007_bib149","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/joim.12279","article-title":"\u2018Vitamin D and cognition in older adults\u2019: updated international recommendations","volume":"277","author":"Annweiler","year":"2015","journal-title":"J Intern Med"},{"key":"10.1016\/j.apsb.2026.04.007_bib150","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1080\/1028415X.2018.1436639","article-title":"Vitamin D status and risk of dementia and Alzheimer\u2019s disease: a meta-analysis of dose-response\u2020","volume":"22","author":"Jayedi","year":"2019","journal-title":"Nutr Neurosci"},{"key":"10.1016\/j.apsb.2026.04.007_bib151","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/1742-2094-9-244","article-title":"Vitamin D mitigates age-related cognitive decline through the modulation of pro-inflammatory state and decrease in amyloid burden","volume":"9","author":"Briones","year":"2012","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.apsb.2026.04.007_bib152","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/ajcn\/nqac107","article-title":"Vitamin D and brain health: an observational and Mendelian randomization study","volume":"116","author":"Navale","year":"2022","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.apsb.2026.04.007_bib153","doi-asserted-by":"crossref","first-page":"6463","DOI":"10.1007\/s12035-017-0839-1","article-title":"Vitamin D improves neurogenesis and cognition in a mouse model of Alzheimer\u2019s disease","volume":"55","author":"Morello","year":"2018","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.apsb.2026.04.007_bib154","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.3390\/nu16132015","article-title":"Vitamin D, the sunshine molecule that makes us strong: what does its current global deficiency imply?.","volume":"16","author":"Riccio","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.apsb.2026.04.007_bib155","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1210\/clinem\/dgae290","article-title":"Vitamin D for the prevention of disease: an endocrine society clinical practice guideline","volume":"109","author":"Demay","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.apsb.2026.04.007_bib156","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s00702-024-02769-z","article-title":"Parkinson\u2019s disease and vitamins: a focus on vitamin B12","volume":"131","author":"Rekik","year":"2024","journal-title":"J Neural Transm"},{"key":"10.1016\/j.apsb.2026.04.007_bib157","doi-asserted-by":"crossref","first-page":"9523","DOI":"10.1073\/pnas.1301816110","article-title":"Preventing Alzheimer\u2019s disease-related gray matter atrophy by B-vitamin treatment","volume":"110","author":"Douaud","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2026.04.007_bib158","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.3390\/genes13081498","article-title":"Relationship between nutrition, lifestyle, and neurodegenerative disease: lessons from ADH1B, CYP1A2 and MTHFR","volume":"13","author":"Barati","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.apsb.2026.04.007_bib159","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/bs.vh.2022.01.001","article-title":"Neuropsychiatric manifestations in vitamin B12 deficiency","volume":"119","author":"Sahu","year":"2022","journal-title":"Vitam Horm"},{"key":"10.1016\/j.apsb.2026.04.007_bib160","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.3390\/antiox11091785","article-title":"Vitamin E and metabolic health: relevance of interactions with other micronutrients","volume":"11","author":"Liao","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.apsb.2026.04.007_bib161","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.trci.2018.06.001","article-title":"Impact of apolipoprotein E genotypes on vitamin E and memantine treatment outcomes in Alzheimer\u2019s disease","volume":"4","author":"Belitskaya-L\u00e9vy","year":"2018","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.apsb.2026.04.007_bib162","doi-asserted-by":"crossref","DOI":"10.3389\/fragi.2024.1426436","article-title":"New insights into healthy ageing, inflammageing and frailty using metabolomics","volume":"5","author":"Abdullah","year":"2024","journal-title":"Front Aging"},{"key":"10.1016\/j.apsb.2026.04.007_bib163","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1200\/JCO.23.01260","article-title":"Plant foods intake and risk of premature aging in adult survivors of childhood cancer in the st jude lifetime cohort (SJLIFE)","volume":"42","author":"Wang","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.apsb.2026.04.007_bib164","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3390\/nu9070670","article-title":"Vitamin C, aging and Alzheimer\u2019s disease","volume":"9","author":"Monacelli","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.apsb.2026.04.007_bib165","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/PSY.0000000000000129","article-title":"Dietary antioxidant intake and its association with cognitive function in an ethnically diverse sample of US adults","volume":"77","author":"Beydoun","year":"2015","journal-title":"Psychosom Med"},{"key":"10.1016\/j.apsb.2026.04.007_bib166","doi-asserted-by":"crossref","DOI":"10.1002\/jcb.30658","article-title":"Role of sodium-dependent vitamin C transporter-2 and ascorbate in regulating the hypoxic pathway in cultured glioblastoma cells","volume":"126","author":"Burgess","year":"2025","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.apsb.2026.04.007_bib167","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.3390\/nu12113286","article-title":"The emerging role of Vitamin C in the prevention and treatment of COVID-19","volume":"12","author":"Carr","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.apsb.2026.04.007_bib168","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0269394","article-title":"Comparative assessment of cognitive impairment and oxidative stress markers among vitamin D insufficient elderly patients with and without type 2 diabetes mellitus (T2DM)","volume":"17","author":"R","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2026.04.007_bib169","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3233\/JAD-171042","article-title":"Homocysteine and dementia: an international consensus statement","volume":"62","author":"Smith","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.apsb.2026.04.007_bib170","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3233\/JAD-220556","article-title":"Supplementation with carotenoids, omega-3 fatty acids, and vitamin E has a positive effect on the symptoms and progression of Alzheimer\u2019s disease","volume":"90","author":"Nolan","year":"2022","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.apsb.2026.04.007_bib171","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jshs.2020.01.004","article-title":"Physical exercise in the prevention and treatment of Alzheimer\u2019s disease","volume":"9","author":"De la Rosa","year":"2020","journal-title":"J Sport Health Sci"},{"key":"10.1016\/j.apsb.2026.04.007_bib172","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2024.1448791","article-title":"Entorhinal cortex\u2013hippocampal circuit connectivity in health and disease","volume":"18","author":"Hern\u00e1ndez-Frausto","year":"2024","journal-title":"Front Hum Neurosci"},{"key":"10.1016\/j.apsb.2026.04.007_bib173","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.2061-23.2024","article-title":"Grandfathers-to-grandsons transgenerational transmission of exercise positive effects on cognitive performance","volume":"44","author":"Cintado","year":"2024","journal-title":"J Neurosci"},{"key":"10.1016\/j.apsb.2026.04.007_bib174","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.3390\/nu13114144","article-title":"The safe and effective use of plant-based diets with guidelines for health professionals","volume":"13","author":"Craig","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.apsb.2026.04.007_bib175","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.14336\/AD.2024.0216","article-title":"Physical exercise counteracts aging-associated white matter demyelination causing cognitive decline","volume":"15","author":"Butt","year":"2024","journal-title":"Aging Dis"},{"key":"10.1016\/j.apsb.2026.04.007_bib176","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.nbd.2012.06.011","article-title":"Exercise counteracts declining hippocampal function in aging and Alzheimer\u2019s disease","volume":"57","author":"Intlekofer","year":"2013","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.apsb.2026.04.007_bib177","series-title":"Guidelines on physical activity and sedentary behaviour","author":"Organization","year":"2024"},{"key":"10.1016\/j.apsb.2026.04.007_bib178","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/bjsports-2013-093184","article-title":"Aerobic exercise increases hippocampal volume in older women with probable mild cognitive impairment: a 6-month randomised controlled trial","volume":"49","author":"ten Brinke","year":"2015","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.apsb.2026.04.007_bib179","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1080\/15548627.2023.2213984","article-title":"Impaired lipophagy induced-microglial lipid droplets accumulation contributes to the buildup of TREM1 in diabetes-associated cognitive impairment","volume":"19","author":"Li","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.apsb.2026.04.007_bib180","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/bjsports-2016-096587","article-title":"Exercise interventions for cognitive function in adults older than 50: a systematic review with meta-analysis","volume":"52","author":"Northey","year":"2018","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.apsb.2026.04.007_bib181","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000200266","article-title":"Combating genetic heterogeneity for polygenic prediction of susceptibility to brain \u03b2-Amyloid deposition: beyond APOE","volume":"11","author":"Ramanan","year":"2025","journal-title":"Neurol Genet"},{"key":"10.1016\/j.apsb.2026.04.007_bib182","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106772","article-title":"The role of the neurovascular unit in vascular cognitive impairment: current evidence and future perspectives","volume":"204","author":"He","year":"2025","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.apsb.2026.04.007_bib183","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000210009","article-title":"Cerebral Amyloid angiopathy, dementia, and Alzheimer neuropathologic changes: findings from the ACT autopsy cohort","volume":"103","author":"Sin","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.apsb.2026.04.007_bib184","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1447734","article-title":"Exercise effects on neuropsychiatric symptoms and quality of life in mild cognitive impairment: a systematic review and meta-analysis","volume":"15","author":"Chen","year":"2024","journal-title":"Front Neurol"},{"key":"10.1016\/j.apsb.2026.04.007_bib185","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00005-022-00653-w","article-title":"Sex differences in innate immune response of peripheral blood leukocytes of Alzheimer\u2019s disease patients","volume":"70","author":"Sochocka","year":"2022","journal-title":"Arch Immunol Ther Exp"},{"key":"10.1016\/j.apsb.2026.04.007_bib186","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.neuron.2024.01.024","article-title":"Mechanisms of sex differences in Alzheimer\u2019s disease","volume":"112","author":"Lopez-Lee","year":"2024","journal-title":"Neuron"},{"key":"10.1016\/j.apsb.2026.04.007_bib187","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s43587-024-00698-w","article-title":"Exploring how APOE \u03b54 increases Alzheimer\u2019s disease risk in women","volume":"4","author":"Gas","year":"2024","journal-title":"Nat Aging"},{"key":"10.1016\/j.apsb.2026.04.007_bib188","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14456","article-title":"Menopausal hormone therapy is associated with worse levels of Alzheimer\u2019s disease biomarkers in APOE \u03b54-carrying women: an observational study","volume":"21","author":"Jauregi-Zinkunegi","year":"2025","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.apsb.2026.04.007_bib189","doi-asserted-by":"crossref","first-page":"225","DOI":"10.14283\/jpad.2018.34","article-title":"Female sex and Alzheimer\u2019s risk: the menopause connection","volume":"5","author":"Scheyer","year":"2018","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.apsb.2026.04.007_bib190","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/j.apsb.2025.02.030","article-title":"Discovery of novel butyrylcholinesterase inhibitors for treating Alzheimer\u2019s disease","volume":"15","author":"Sang","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.04.007_bib191","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.apsb.2025.01.015","article-title":"Enhanced BBB penetration and microglia-targeting nanomodulator for the two-pronged modulation of chronically activated microglia-mediated neuroinflammation in Alzheimer\u2019s disease","volume":"15","author":"Wei","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.04.007_bib192","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2026.04.007_bib193","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/jamaneurol.2024.3770","article-title":"Alzheimer disease as a clinical-biological construct-an international working group recommendation","volume":"81","author":"Dubois","year":"2024","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.apsb.2026.04.007_bib194","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1134\/S0006297923140055","article-title":"Role of interaction between zinc and amyloid beta in pathogenesis of Alzheimer\u2019s disease","volume":"88","author":"Kozin","year":"2023","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.apsb.2026.04.007_bib195","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/biof.199","article-title":"A potential role for zinc alterations in the pathogenesis of Alzheimer\u2019s disease","volume":"38","author":"Lyubartseva","year":"2012","journal-title":"Biofactors"},{"key":"10.1016\/j.apsb.2026.04.007_bib196","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpc.2025.110197","article-title":"Adolescent marginal zinc deficiency upregulated BDNF and TrkB expression, impaired hippocampal and cortical development, and induced abnormal behaviors in male mice","volume":"294","author":"Li","year":"2025","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"key":"10.1016\/j.apsb.2026.04.007_bib197","first-page":"623","article-title":"Disruption of brain zinc homeostasis promotes the pathophysiological progress of Alzheimer\u2019s disease","volume":"31","author":"Li","year":"2016","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.apsb.2026.04.007_bib198","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.neurobiolaging.2007.10.012","article-title":"Zinc and copper modulate Alzheimer Abeta levels in human cerebrospinal fluid","volume":"30","author":"Strozyk","year":"2009","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.apsb.2026.04.007_bib199","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70351","article-title":"Baseline characteristics of the U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER): successful enrollment of a diverse clinical trial cohort at risk for cognitive decline","volume":"21","author":"Whitmer","year":"2025","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.apsb.2026.04.007_bib200","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/alz.13365","article-title":"Study design and methods: U.S. study to protect brain health through lifestyle intervention to reduce risk (U.S. POINTER)","volume":"20","author":"Baker","year":"2024","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.apsb.2026.04.007_bib201","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/jama.2018.21442","article-title":"Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial","volume":"321","author":"Williamson","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.apsb.2026.04.007_bib202","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(23)01406-X","article-title":"Hearing intervention versus health education control to reduce cognitive decline in older adults with hearing loss in the USA (ACHIEVE): a multicentre, randomised controlled trial","volume":"402","author":"Lin","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2026.04.007_bib203","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/S0140-6736(15)60461-5","article-title":"A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial","volume":"385","author":"Ngandu","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2026.04.007_bib204","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1038\/s41591-025-03891-5","article-title":"Interplay of genetic predisposition, plasma metabolome and Mediterranean diet in dementia risk and cognitive function","volume":"31","author":"Liu","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2026.04.007_bib205","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1056\/NEJMoa2302368","article-title":"Trial of the MIND diet for prevention of cognitive decline in older persons","volume":"389","author":"Barnes","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.04.007_bib206","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","article-title":"Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission","volume":"404","author":"Livingston","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2026.04.007_bib207","doi-asserted-by":"crossref","DOI":"10.1016\/j.maturitas.2025.108217","article-title":"Dementia prevention, intervention, and care: comments on the 2024 report of the Lancet standing Commission","volume":"195","author":"Depypere","year":"2025","journal-title":"Maturitas"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526002467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526002467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T18:51:31Z","timestamp":1783018291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383526002467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":207,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2211383526002467"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2026.04.007","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The mechanisms and strategies for Alzheimer\u2019s disease prevention: An update","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2026.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}